TrialThe AAPS journal2018

Application of the Stable Isotope Label Approach in Clinical Development-Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound.

Navin Goyal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.